Victoria Gray
CRISPR for sickle-cell, one year on
As the one year anniversary of her receiving a ground-breaking treatment for sickle-cell disease approaches, it’s good news for Victoria Gray — the first person in the United States to undergo CRISPR gene therapy to treat a genetic disorder. It’s too soon for scientists to reach firm conclusions about the long-term safety and effectiveness of the approach. But for Gray, life is very different from the severe pain attacks and frequent blood transfusions she experienced before. “It's hard to put into words the joy that I feel — being grateful for a change this big. It's been amazing,” said Gray.
NPR | 7 min read or 6 min listenRead more: Gene therapy is facing its biggest challenge yet: sickle-cell disease (Nature | 13 min read, from December)
No hay comentarios:
Publicar un comentario